Jun 04, 2018

FDS, Inc. Announces New CEO

Fort Worth, TX  - June 04, 2018 -  FDS, Inc. announced today the appointment of Adam McMullin as Chief Executive Officer (CEO), effective immediately. McMullin succeeds Jake Canova, who will continue to work with FDS in an advisory capacity after spending seven years as its CEO. 

“We are very pleased to partner with Adam to lead FDS. His broad experience in healthcare IT will be invaluable as the company continues to innovate and grow in pharmacy technology and beyond,” said Michael Booth, a Partner with Calvert Street Capital Partners, FDS’s majority shareholder.

An experienced leader in healthcare IT, McMullin has a proven track record of leading high-performance teams in the development of solutions that drive healthcare efficiencies and improve patient outcomes. He has also successfully grown multiple businesses that delivered high-value health IT solutions and outstanding customer service.

Most recently, McMullin was Chairman and CEO of Voalte, a leader in healthcare communication technology, where he increased revenues and improved operations. Previously, he led Hill-Rom’s Clinical Workflow Solutions business, doubling revenues and dramatically increasing earnings and customer satisfaction within five years. He also spent more than a decade in various management roles at IBM. 

McMullin holds a Bachelor of Science in Electrical Engineering from the Georgia Institute of Technology and a Master of Business Administration from the University of Georgia.

“FDS has built a strong reputation in the market based on its team’s deep commitment to customer success and its unique solutions that help ensure patients are getting the medications they need while improving pharmacy efficiency and profitability,” said McMullin. “Pharmacies represent a key part of our health system, playing a critical role in improving wellness within communities. While we will continue delivering high-value solutions and outstanding services to pharmacies, we also see many opportunities for innovations that will further help pharmacies and improve population health. I look forward to building on FDS’s leadership position and continuing to grow the business.” 

About Calvert Street Capital Partners
Calvert Street is a Baltimore, Maryland-based private equity firm focused on investing in businesses in the lower middle-market. Since its inception in 1995, Calvert Street’s objective has been to partner with skilled management teams of privately held businesses to drive profitable growth and organizational transformation. For more information, please go to www.cscp.com.  

 

About FDS, Inc.
FDS, Inc. is a leading provider of technology solutions to the pharmacy and broader healthcare markets. FDS’s solution set includes a wide variety of technology tools that help pharmacies manage financial billing and reconciliation activities, better understand their business through data analytics and actionable business intelligence, and their population health activities including Star Ratings, medication adherence, medication synchronization and much more. FDS’s tools are easy to use but provide tremendous value for both pharmacies and patients. For additional information or to request a demonstration, please visit our website at www.fdsrx.com or call us at (877) 602-4179.

Market Buzz

Jun 03, 2019 PrimeCare® Integrates MedTek21® to Offer Facility-based Genomic Testing
May 22, 2019 Letco Med Announces the Launch of a New Industry-Leading Website and E-Commerce ...
May 17, 2019 MEDISCA Granted Planetary Mixing Patent and Exclusive Distribution Agreement
May 02, 2019 Transaction Data Systems (TDS) Delivers Smarter Approach to Claim Reconciliation
Apr 22, 2019 Visante healthcare consulting firm announces Judi Jacobi, PharmD, to join consul...
Apr 17, 2019 As an aging population demands more efficient pharmacy solutions, the founder of...
Apr 17, 2019 Adam Wallace Named Chief Technology Officer at Transaction Data Systems (TDS)
Apr 15, 2019 PharmaLink to Exhibit at 2019 Asembia Specialty Pharmacy Summit
Apr 04, 2019 Transaction Data Systems (TDS) Announces Acquisition of Pharm Assess, Inc.
Apr 01, 2019 Chad Collins Named President of Akro-Mils and Jamco Products
Mar 22, 2019 Tutela Welcomes Octapharma Plasma
Mar 18, 2019 Verity Solutions Recognized as Category Leader for 340B Management Systems in 20...
Mar 07, 2019 Stormont Vail Health Partners with Omnicell to Enhance Medication Management Str...
Mar 06, 2019 Rebranding Focuses ALG Mission - Combining Our Best to Bring You Our Best
Mar 04, 2019 RXinsider Celebrates 20 Years, 1999 - 2019
Feb 28, 2019 Lupin launches Generic Ranolazine ER Tablets in U.S.
Feb 18, 2019 QS/1® Offers Compliance Packaging Label Solution
Feb 15, 2019 QS/1 Partnership Offers Compliant Patient Communications
Feb 14, 2019 RXinsider is Proud to Welcome our Newest Partners!
Feb 12, 2019 Albertsons Companies Pharmacies Adopt TemperPack's ClimaCell™ Packaging
Feb 07, 2019 Fagron Launches New Brand Identity and Purpose
Feb 07, 2019 Medicine-On-Time has come together with Clinical Support Services, a leader in M...
Feb 04, 2019 Letco Med and Ananda Professional Partner to Bring CBD and Education to Compound...
Jan 30, 2019 Texas Children’s Hospital Expands Partnership with Omnicell
Jan 16, 2019 Helmer Scientific Launches the First Professional Medical-grade Refrigerators
Jan 15, 2019 The Compliance Team™ celebrates 25 years of accreditation transformation
Jan 11, 2019 CORE Higher Education Group partners with Pharmacists Mutual
Jan 10, 2019 SCA Pharma Awarded National Outsourced I.V. Admixture Services Agreement with Pr...
Jan 08, 2019 Tutela Welcomes the Center for Organ Recovery and Education
Dec 13, 2018 PharmaLink Launches Updated Website

RXinsider Product Overview Videos